They are caregivers, therapists, and advocates, fighting for their children’s health amid financial hardship and limited access to care.
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
Christina Sanz, 32, underwent a mastectomy and chemotherapy while pregnant and later gave birth to a healthy baby girl, ...